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There currently exists a dire need for safe and inexpensive new antimalarial drugs, which are 
effective against multiple life cycle stages of Plasmodium falciparum, and act through mechanisms that 
differ from those of the available drugs to prevent drug resistance. The enzyme glucose-6-phosphate 
dehydrogenase (G6PD) of P. falciparum has emerged as a promising target for antimalarial drug 
discovery, due to its key role in parasite development and survival and its protective effect against 
malaria infection observed under human G6PD deficiency conditions. Here, we describe the 
construction of a homology model of PfG6PD, which has enabled the identification of key structural 
differences as compared with the human enzyme. We have exploited these changes to rationally 
design a novel family of substrate analog-based inhibitors that can be endowed with selectivity 
towards PfG6PD. Several compounds display micromolar affinity, good selectivity, and low 
cytotoxicity, but weak antiplasmodial activity in phenotypic assays, likely as a result of a poor 
internalization of the compounds in the parasite cell. Future hit optimization should focus on 
improving the physicochemical/pharmacokinetic properties of this class of compounds. 
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